RSS

molecular diagnostic test

£16 million has been awarded to university-led projects for the development of molecular pathology tests that help deliver stratified medicine. more

News

BioNTech has announced the launch of its MammaTyper, a CE-IVD marked molecular diagnostic test to stratify breast cancer patients by molecular subtyping of routine tumour tissue. more

News